Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
65.33 USD | -0.27% | -2.61% | -19.36% |
02.05. | GILEAD SCIENCES, INC. : UBS gibt eine neutrale Bewertung ab | ZM |
01.05. | GILEAD SCIENCES, INC. : erhält Verkaufen-Bewertung von Deutsche Bank Securities | ZM |
Filter: Derivate
Börse
Nordamerika
Südamerika
Europa
Afrika
Mittlerer Osten
Asien
Ozeanien
Mittelamerika
Emittent
Produkttyp
Typ
Fälligkeit
Nur für Hebelprodukte verfügbar
Hebel / Elastizität
Derivate
WKN | Typ | Basispreis | Fälligkeit | Elastizität | Delta | Parität | Kurs | Emittent | ||
---|---|---|---|---|---|---|---|---|---|---|
CALL
| CALL | 140 € | 21.06.2024 | 7.65x | 0.033 | 10 | 0.012 EUR |
Morgan Stanley
| ||
CALL
| CALL | 140 € | 17.01.2025 | 7.38x | 0.036 | 10 | 0.055 0.005 |
Goldman Sachs
| ||
CALL
| CALL | 140 € | 21.06.2024 | 7.64x | 0.033 | 10 | 0.051 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 140 € | 20.06.2025 | 6.94x | 0.042 | 10 | 0.034 EUR |
Morgan Stanley
| ||
CALL
| CALL | 140 € | 20.06.2025 | 7.53x | 0.032 | 10 | 0.036 0.016 |
Goldman Sachs
| ||
CALL
| CALL | 130 € | 21.06.2024 | 8.15x | 0.035 | 10 | 0.012 EUR |
Morgan Stanley
| ||
CALL
| CALL | 130 € | 20.12.2024 | 7.73x | 0.04 | 10 | 0.023 EUR |
Morgan Stanley
| ||
CALL
| CALL | 130 € | 18.06.2025 | 0 | 10 | 0.008 EUR |
UniCredit
| |||
CALL
| CALL | 130 € | 20.06.2025 | 7.31x | 0.046 | 10 | 0.037 EUR |
Morgan Stanley
| ||
CALL
| CALL | 130 € | 17.05.2024 | 9.19x | 0.024 | 10 | 0.031 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 130 € | 21.06.2024 | 11.1x | 0.011 | 10 | 0.011 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 127.5 € | 21.06.2024 | 8.27x | 0.035 | 10 | 0.012 EUR |
Morgan Stanley
| ||
CALL
| CALL | 125 € | 20.06.2024 | 0 | 10 | 0.001 EUR |
Citi
| |||
CALL
| CALL | 125 € | 20.12.2024 | 8.03x | 0.041 | 10 | 0.023 EUR |
Morgan Stanley
| ||
CALL
| CALL | 125 € | 20.09.2024 | 8.25x | 0.039 | 10 | 0.017 EUR |
Morgan Stanley
| ||
CALL
| CALL | 125 € | 20.06.2025 | 7.54x | 0.048 | 10 | 0.037 EUR |
Morgan Stanley
| ||
CALL
| CALL | 120 € | 19.06.2024 | 11.28x | 0.016 | 10 | 0.016 0.001 |
HSBC
| ||
CALL
| CALL | 120 € | 21.06.2024 | 8.76x | 0.037 | 10 | 0.012 EUR |
Morgan Stanley
| ||
CALL
| CALL | 120 € | 15.01.2025 | 0 | 10 | 0.001 EUR |
UniCredit
| |||
CALL
| CALL | 120 € | 20.12.2024 | 8.34x | 0.043 | 10 | 0.023 EUR |
Morgan Stanley
| ||
CALL
| CALL | 120 € | 15.01.2025 | 11.29x | 0.016 | 10 | 0.001 EUR |
HSBC
| ||
CALL
| CALL | 120 € | 21.06.2024 | 8.78x | 0.037 | 10 | 0.051 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 120 € | 17.01.2025 | 8.34x | 0.044 | 10 | 0.057 0.007 |
Goldman Sachs
| ||
CALL
| CALL | 120 € | 18.06.2025 | 0 | 10 | 0.013 EUR |
UniCredit
| |||
CALL
| CALL | 120 € | 20.06.2025 | 7.71x | 0.052 | 10 | 0.041 EUR |
Morgan Stanley
| ||
CALL
| CALL | 120 € | 20.09.2024 | 8.56x | 0.04 | 10 | 0.017 EUR |
Morgan Stanley
| ||
CALL
| CALL | 120 € | 17.05.2024 | 10.83x | 0.02 | 10 | 0.021 0.001 |
Goldman Sachs
| ||
CALL
| CALL | 120 € | 20.06.2025 | 7.99x | 0.047 | 10 | 0.016 EUR |
J.P. Morgan
| ||
CALL
| CALL | 120 € | 20.06.2025 | 7.77x | 0.051 | 10 | 0.055 0.025 |
Goldman Sachs
| ||
CALL
| CALL | 120 € | 16.01.2026 | 7.55x | 0.055 | 10 | 0.05 0.04 |
Goldman Sachs
| ||
CALL
| CALL | 120 € | 16.08.2024 | 11.9x | 0.014 | 10 | 0.012 0.002 |
Goldman Sachs
| ||
CALL
| CALL | 120 € | 21.03.2025 | 8.1x | 0.047 | 10 | 0.03 EUR |
Morgan Stanley
| ||
CALL
| CALL | 115 € | 21.06.2024 | 9.17x | 0.039 | 10 | 0.012 EUR |
Morgan Stanley
| ||
CALL
| CALL | 115 € | 20.06.2025 | 7.85x | 0.058 | 10 | 0.044 EUR |
Morgan Stanley
| ||
CALL
| CALL | 115 € | 20.12.2024 | 8.68x | 0.046 | 10 | 0.024 EUR |
Morgan Stanley
| ||
CALL
| CALL | 115 € | 20.09.2024 | 8.94x | 0.042 | 10 | 0.017 EUR |
Morgan Stanley
| ||
CALL
| CALL | 115 € | 20.06.2025 | 8.28x | 0.05 | 10 | 0.023 EUR |
J.P. Morgan
| ||
CALL
| CALL | 112.5 € | 21.06.2024 | 9.43x | 0.04 | 10 | 0.012 EUR |
Morgan Stanley
| ||
CALL
| CALL | 112.5 € | 20.12.2024 | 8.86x | 0.047 | 10 | 0.025 EUR |
Morgan Stanley
| ||
CALL
| CALL | 112.5 € | 20.09.2024 | 9.17x | 0.043 | 10 | 0.017 EUR |
Morgan Stanley
| ||
- Börse
- Aktien
- 885823 Aktie
- Derivate Gilead Sciences, Inc.
- Optionsscheine